+
Open data
-
Basic information
| Entry | ![]() | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Title | PfMSP3 in complex with mAb MP3.01 | |||||||||
Map data | PfMSP3 in complex with mAb MP3.01 | |||||||||
Sample |
| |||||||||
Keywords | Malaria / complement regulation / C1-INH / Plasmodium falciparum / MSP3 / neutralizing antibody / IMMUNE SYSTEM | |||||||||
| Function / homology | Merozoite surface protein-type / Merozoite surface protein (SPAM) / Merozoite surface protein 3 Function and homology information | |||||||||
| Biological species | ![]() | |||||||||
| Method | single particle reconstruction / cryo EM / Resolution: 3.7 Å | |||||||||
Authors | Bjoernsson KH / Barfod L / Ward AB | |||||||||
| Funding support | Denmark, 1 items
| |||||||||
Citation | Journal: PLoS Pathog / Year: 2025Title: Deposition of complement regulators on the surface of Plasmodium falciparum merozoites depends on the immune status of the host. Authors: Maria Rosaria Bassi / Bogdan Cristinoi / Frank Buitenwerf / Mark Bergholt Cuadrado / Kasper Haldrup Björnsson / Melanie Rose Walker / Frederica Dedo Partey / Andrew B Ward / Michael Fokuo Ofori / Lea Barfod / ![]() Abstract: Plasmodium falciparum is responsible for the majority of malaria cases and deaths worldwide. In malaria endemic areas, natural immunity to blood stage infection is acquired over several exposures to ...Plasmodium falciparum is responsible for the majority of malaria cases and deaths worldwide. In malaria endemic areas, natural immunity to blood stage infection is acquired over several exposures to the parasite and is thought to rely on antibodies. Antibodies can protect from severe disease through different effector functions, with complement activation lately emerging as an important feature of protective humoral responses to malaria. Plasmodium parasites have however evolved several mechanisms to evade complement attack, including the recruitment of complement down-regulatory proteins like Factor H (FH) and C1 esterase inhibitor (C1-INH). In this study, we report that merozoite-specific antibodies acquired naturally after infection activate the complement cascade in an exposure-dependent manner. Using plasma samples from convalescent children and exposed adults collected respectively in Hohoe and Accra (Ghana), we show that the ability to fix C1q and activate the classical pathway is similar for antibodies deriving from the two donors groups. However, downstream complement activation shown as deposition of the membrane attack complex (MAC) is strikingly higher with antibodies from children compared to antibodies from adults. Moreover, we demonstrate that antibodies from naturally exposed children can interfere with the merozoite recruitment of FH, but not of C1-INH. With the aim of neutralizing parasite evasion of the complement classical pathway, we develop a murine monoclonal antibody targeting PfMSP3, the binding partner of C1-INH on the merozoite surface. We demonstrate that this antibody can effectively block the binding of C1-INH to the parasite surface, unlike the naturally acquired ones. Using cryogenic electron microscopy, we obtain a low-resolution structure of the monoclonal antibody in complex with PfMSP3, which is the first reported structural data for this antigen. We propose targeting parasite antigens binding to complement down-regulators, together with leading vaccine candidate antigens, as a novel strategy to enhance the efficacy of future malaria vaccines. | |||||||||
| History |
|
-
Structure visualization
| Supplemental images |
|---|
-
Downloads & links
-EMDB archive
| Map data | emd_51634.map.gz | 117.7 MB | EMDB map data format | |
|---|---|---|---|---|
| Header (meta data) | emd-51634-v30.xml emd-51634.xml | 16.4 KB 16.4 KB | Display Display | EMDB header |
| FSC (resolution estimation) | emd_51634_fsc.xml | 10.7 KB | Display | FSC data file |
| Images | emd_51634.png | 44.6 KB | ||
| Filedesc metadata | emd-51634.cif.gz | 5.2 KB | ||
| Others | emd_51634_half_map_1.map.gz emd_51634_half_map_2.map.gz | 116 MB 116 MB | ||
| Archive directory | http://ftp.pdbj.org/pub/emdb/structures/EMD-51634 ftp://ftp.pdbj.org/pub/emdb/structures/EMD-51634 | HTTPS FTP |
-Validation report
| Summary document | emd_51634_validation.pdf.gz | 961.2 KB | Display | EMDB validaton report |
|---|---|---|---|---|
| Full document | emd_51634_full_validation.pdf.gz | 960.8 KB | Display | |
| Data in XML | emd_51634_validation.xml.gz | 19.1 KB | Display | |
| Data in CIF | emd_51634_validation.cif.gz | 24.8 KB | Display | |
| Arichive directory | https://ftp.pdbj.org/pub/emdb/validation_reports/EMD-51634 ftp://ftp.pdbj.org/pub/emdb/validation_reports/EMD-51634 | HTTPS FTP |
-Related structure data
| Similar structure data | Similarity search - Function & homology F&H Search |
|---|
-
Links
| EMDB pages | EMDB (EBI/PDBe) / EMDataResource |
|---|
-
Map
| File | Download / File: emd_51634.map.gz / Format: CCP4 / Size: 125 MB / Type: IMAGE STORED AS FLOATING POINT NUMBER (4 BYTES) | ||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | PfMSP3 in complex with mAb MP3.01 | ||||||||||||||||||||||||||||||||||||
| Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
| Voxel size | X=Y=Z: 0.718 Å | ||||||||||||||||||||||||||||||||||||
| Density |
| ||||||||||||||||||||||||||||||||||||
| Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
| Details | EMDB XML:
|
-Supplemental data
-Half map: PfMSP3 in complex with mAb MP3.0 - half map A
| File | emd_51634_half_map_1.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | PfMSP3 in complex with mAb MP3.0 - half map A | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-Half map: PfMSP3 in complex with mAb MP3.0 - half map B
| File | emd_51634_half_map_2.map | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annotation | PfMSP3 in complex with mAb MP3.0 - half map B | ||||||||||||
| Projections & Slices |
| ||||||||||||
| Density Histograms |
-
Sample components
-Entire : PfMSP3 in complex with neutralizing mAb MP3.01
| Entire | Name: PfMSP3 in complex with neutralizing mAb MP3.01 |
|---|---|
| Components |
|
-Supramolecule #1: PfMSP3 in complex with neutralizing mAb MP3.01
| Supramolecule | Name: PfMSP3 in complex with neutralizing mAb MP3.01 / type: complex / ID: 1 / Parent: 0 / Macromolecule list: all |
|---|---|
| Source (natural) | Organism: ![]() |
-Macromolecule #1: PfMSP3
| Macromolecule | Name: PfMSP3 / type: protein_or_peptide / ID: 1 / Details: PfMSP3, rat CD4 tag, biotinylation site / Enantiomer: LEVO |
|---|---|
| Source (natural) | Organism: ![]() |
| Recombinant expression | Organism: Homo sapiens (human) |
| Sequence | String: KEIVKKYNLN LRNAILNNNA QIENEENVNT AITGNDFSGG EFLWPGYTEE LKAKKASEDA EKAANDAENA AKEAEEAAKE AVNLKESDKS YTKAKEACTA ASKAKKAVET ALKAKDDAEK SSKADSISTK TKEYAEKAKN AYEKAKNAYQ KANQAVLKAK EASSYDYILG ...String: KEIVKKYNLN LRNAILNNNA QIENEENVNT AITGNDFSGG EFLWPGYTEE LKAKKASEDA EKAANDAENA AKEAEEAAKE AVNLKESDKS YTKAKEACTA ASKAKKAVET ALKAKDDAEK SSKADSISTK TKEYAEKAKN AYEKAKNAYQ KANQAVLKAK EASSYDYILG WEFGGGVPEH KKEENMLSHL YVSSKDKENI AKENDDVLDE KEEEAEETEE EELEEKNEEE TESEISEDEE EEEEEEEKEE ENDKKKEQEK EQSNENNDQK KDMEAQNLIS KNQNNNEKNV KEAAESIMKT LAGLIKGNNQ IDSTLKDLVE ELSKYFKNHG APSTSITAYK SEGESAEFSF PLNLGEESLQ GELRWKAEKA PSSQSWITFS LKNQKVSVQK STSNPKFQLS ETLPLTLQIP QVSLQFAGSG NLTLTLDRGI LYQEVNLVVM KVTQPDSNTL TCEVMGPTSP KMRLILKQEN QEARVSRQEK VIQVQAPEAG VWQCLLSEGE EVKMDSKIQV LSKGLNSGSL HHILDAQKMV WNHR UniProtKB: Merozoite surface protein 3 |
-Experimental details
-Structure determination
| Method | cryo EM |
|---|---|
Processing | single particle reconstruction |
| Aggregation state | particle |
-
Sample preparation
| Concentration | 1.1 mg/mL |
|---|---|
| Buffer | pH: 7.4 |
| Grid | Model: UltrAuFoil R1.2/1.3 / Material: GOLD / Mesh: 300 / Pretreatment - Type: GLOW DISCHARGE / Pretreatment - Time: 60 sec. |
| Vitrification | Cryogen name: ETHANE / Chamber humidity: 100 % / Chamber temperature: 277 K / Instrument: FEI VITROBOT MARK IV |
| Details | PfMSP3 complexed with Fab of mAb MP3.01 |
-
Electron microscopy
| Microscope | TFS GLACIOS |
|---|---|
| Image recording | Film or detector model: FEI FALCON IV (4k x 4k) / Average electron dose: 60.0 e/Å2 |
| Electron beam | Acceleration voltage: 200 kV / Electron source: FIELD EMISSION GUN |
| Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Nominal defocus max: 2.0 µm / Nominal defocus min: 0.8 µm / Nominal magnification: 195000 |
| Sample stage | Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER / Cooling holder cryogen: NITROGEN |
Movie
Controller
About Yorodumi




Keywords
Authors
Denmark, 1 items
Citation
Z (Sec.)
Y (Row.)
X (Col.)




































Homo sapiens (human)
Processing
FIELD EMISSION GUN
